These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24772915)

  • 61. Epigenetic Treatment Options in Urothelial Carcinoma.
    Pinkerneil M; Hoffmann MJ; Niegisch G
    Methods Mol Biol; 2018; 1655():289-317. PubMed ID: 28889393
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells.
    Bar-Sela G; Jacobs KM; Gius D
    Cancer J; 2007; 13(1):65-9. PubMed ID: 17464248
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Radiosensitization by the histone deacetylase inhibitor PCI-24781.
    Banuelos CA; Banáth JP; MacPhail SH; Zhao J; Reitsema T; Olive PL
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6816-26. PubMed ID: 18006784
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
    Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
    Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Histone Deacetylase Inhibitors Sensitize Murine B16F10 Melanoma Cells to Carbon Ion Irradiation by Inducing G1 Phase Arrest.
    Saito K; Funayama T; Yokota Y; Murakami T; Kobayashi Y
    Biol Pharm Bull; 2017; 40(6):844-851. PubMed ID: 28566628
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma.
    Vandermeers F; Hubert P; Delvenne P; Mascaux C; Grigoriu B; Burny A; Scherpereel A; Willems L
    Clin Cancer Res; 2009 Apr; 15(8):2818-28. PubMed ID: 19351772
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines.
    Lee CM; Fuhrman CB; Planelles V; Peltier MR; Gaffney DK; Soisson AP; Dodson MK; Tolley HD; Green CL; Zempolich KA
    Clin Cancer Res; 2006 Jan; 12(1):250-6. PubMed ID: 16397049
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation.
    Kawano T; Akiyama M; Agawa-Ohta M; Mikami-Terao Y; Iwase S; Yanagisawa T; Ida H; Agata N; Yamada H
    Int J Oncol; 2010 Oct; 37(4):787-95. PubMed ID: 20811699
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sensitization of cervical cancer cell lines to low-dose radiation by retinoic acid does not require functional p53.
    Tillmanns TD; Kamelle SA; Guruswamy S; Gould NS; Rutledge TL; Benbrook DM
    Gynecol Oncol; 2005 Apr; 97(1):142-50. PubMed ID: 15790450
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of buffalo (Bubalus bubalis) donor cells with trichostatin A and 5-aza-2'-deoxycytidine alters their growth characteristics, gene expression and epigenetic status and improves the in vitro developmental competence, quality and epigenetic status of cloned embryos.
    Saini M; Selokar NL; Agrawal H; Singla SK; Chauhan MS; Manik RS; Palta P
    Reprod Fertil Dev; 2016 Apr; 28(6):824-37. PubMed ID: 25409339
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of valproic acid in comparison with vorinostat on cell growth inhibition and apoptosis induction in the human colon cancer SW48 cells in vitro.
    Sanaei M; Kavoosi F; Mansoori O
    Exp Oncol; 2018 Jun; 40(2):95-100. PubMed ID: 29949538
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity.
    Tesei A; Brigliadori G; Carloni S; Fabbri F; Ulivi P; Arienti C; Sparatore A; Del Soldato P; Pasini A; Amadori D; Silvestrini R; Zoli W
    J Cell Physiol; 2012 Oct; 227(10):3389-96. PubMed ID: 22212895
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.
    Wawruszak A; Luszczki JJ; Grabarska A; Gumbarewicz E; Dmoszynska-Graniczka M; Polberg K; Stepulak A
    PLoS One; 2015; 10(11):e0143013. PubMed ID: 26580554
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Sodium valproate enhances doxorubicin cytotoxicity in breast cancer cells in vitro].
    Tong XH; Zheng C; Jiang GJ; Dong SY
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):62-5. PubMed ID: 25613611
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of nuclear-donor cells or cloned zygotes with chromatin-modifying agents increases histone acetylation but does not improve full-term development of cloned cattle.
    Sangalli JR; De Bem TH; Perecin F; Chiaratti MR; Oliveira Lde J; de Araújo RR; Valim Pimentel JR; Smith LC; Meirelles FV
    Cell Reprogram; 2012 Jun; 14(3):235-47. PubMed ID: 22468998
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of histone deacetylase inhibitory prodrugs on epigenetic changes and DNA damage response in tumor and heart of glioblastoma xenograft.
    Tarasenko N; Nudelman A; Rozic G; Cutts SM; Rephaeli A
    Invest New Drugs; 2017 Aug; 35(4):412-426. PubMed ID: 28315153
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibitory effects of valproic acid in DNA double-strand break repair after irradiation in esophageal squamous carcinoma cells.
    Makita N; Ninomiya I; Tsukada T; Okamoto K; Harada S; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
    Oncol Rep; 2015 Sep; 34(3):1185-92. PubMed ID: 26135807
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma.
    Venturelli S; Armeanu S; Pathil A; Hsieh CJ; Weiss TS; Vonthein R; Wehrmann M; Gregor M; Lauer UM; Bitzer M
    Cancer; 2007 May; 109(10):2132-41. PubMed ID: 17407132
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells.
    Pérez-Cárdenas E; Taja-Chayeb L; Trejo-Becerril C; Chanona-Vilchis J; Chávez-Blanco A; Domínguez-Gómez G; Langley E; García-Carrancá A; Dueñas-González A
    Onco Targets Ther; 2018; 11():8823-8833. PubMed ID: 30584338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.